Herbreteau, G., Vallée, A., Knol, A., Théoleyre, S., Quéreux, G., Frénard, C., . . . Denis, M. G. (2020). Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients. Cancers (Basel).
シカゴスタイル引用形Herbreteau, Guillaume, et al. "Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients." Cancers (Basel) 2020.
MLA引用形式Herbreteau, Guillaume, et al. "Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients." Cancers (Basel) 2020.
警告: この引用は必ずしも正確ではありません.